Document Detail


Which phototherapy system is most effective in lowering serum bilirubin in very preterm infants?
MedLine Citation:
PMID:  16491004     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: To compare the effectiveness of various phototherapy systems in lowering serum bilirubin levels in preterm infants. METHODS: This randomized clinical trial enrolled 140 preterm infants with gestational age < or =30 weeks and presenting nonhemolytic hyperbilirubinemia. When total serum bilirubin level reached 6.0 mg/dl (102.6 micromol/l), eligible infants were randomly assigned to four study groups: conventional, fiberoptic Wallaby, fiberoptic Biliblanket, and combined phototherapy. Efficacy was assessed by comparing highest serum bilirubin levels, duration of treatment, and number of infants requiring exchange transfusion. RESULTS: Our results confirm that fiberoptic phototherapy, both Wallaby and Biliblanket, had the same effectiveness of conventional phototherapy. The best results have been obtained using combined phototherapy, which allowed to reach lower serum bilirubin levels, a shorter duration of treatment and a significant reduction of exchange transfusions. CONCLUSION: Our data suggest that combined phototherapy should be the method of choice in treating hyperbilirubinemia in very preterm infants.
Authors:
Costantino Romagnoli; Enrico Zecca; Patrizia Papacci; Giovanni Vento; Pietro Girlando; Caterina Latella
Related Documents :
7097424 - Jaundice meter: evaluation of new guidelines.
20174734 - Hyperbilirubinemia in glucose-6-phosphate dehydrogenase-deficient male newborns in al-a...
20722994 - 'halving the heel pricks': evaluation of a neonatal jaundice protocol incorporating the...
12208094 - Kernicterus: an international perspective.
6989554 - The siemens-elema servo ventilator 900 b for the management of newborn infants with sev...
24831524 - Antenatal predictors and body composition of large-for-gestational-age newborns: perina...
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  Fetal diagnosis and therapy     Volume:  21     ISSN:  1015-3837     ISO Abbreviation:  Fetal. Diagn. Ther.     Publication Date:  2006  
Date Detail:
Created Date:  2006-02-21     Completed Date:  2006-06-06     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9107463     Medline TA:  Fetal Diagn Ther     Country:  Switzerland    
Other Details:
Languages:  eng     Pagination:  204-9     Citation Subset:  IM    
Copyright Information:
(c) 2006 S. Karger AG, Basel
Affiliation:
Division of Neonatology, Catholic University of Rome, Rome, Italy. cromagnoli@rm.unicatt.it
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Bilirubin / blood*
Female
Humans
Hyperbilirubinemia, Neonatal / therapy*
Infant, Low Birth Weight
Infant, Newborn
Infant, Premature
Infant, Premature, Diseases / therapy*
Infant, Very Low Birth Weight
Male
Phototherapy / instrumentation*,  methods
Time Factors
Chemical
Reg. No./Substance:
635-65-4/Bilirubin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Congenital heart diseases in twin pregnancies.
Next Document:  Histological evaluation of acute covering of an experimental neural tube defect with biomatrices in ...